Pharma poised to cash in on ‘long COVID’ symptomsWhile there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue Share XPharma poised to cash in on ‘long COVID’ symptomshttps://pharmaphorum.com/news/big-pharma-could-cash-in-on-long/
PureTech begins trial of potential ‘Long COVID’ drug as cases mountAs the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after Share XPureTech begins trial of potential ‘Long COVID’ drug as cases mounthttps://pharmaphorum.com/news/puretech-begins-trial-of-potential-long-covid-drug-as-cases-mount/
